PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022
Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022 market report to its offering
The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.
View full press release